Lvrn - laeverin Gene
Also Known as Aqpep; RGD1562779
Species: Rattus norvegicus
Gene Type: protein coding
Gene ID: 502160
Summary
Predicted to enable metalloaminopeptidase activity; peptide binding activity; and zinc ion binding activity. Predicted to be involved in several processes, including peptide catabolic process; proteolysis; and regulation of blood pressure. Predicted to be active in cytoplasm and plasma membrane. Orthologous to human LVRN (laeverin). [provided by Alliance of Genome Resources, Apr 2022]
Lvrn Products (9)
| mRNA | Protein | Name |
|---|---|---|
| XM_039097206.1 | XP_038953134.1 | aminopeptidase Q isoform X1 |
| XM_039097209.1 | XP_038953137.1 | aminopeptidase Q isoform X4 |
| XM_039097208.1 | XP_038953136.1 | aminopeptidase Q isoform X3 |
| XM_039097207.1 | XP_038953135.1 | aminopeptidase Q isoform X2 |
| XM_039097210.1 | XP_038953138.1 | aminopeptidase Q isoform X5 |
| XM_039097213.1 | XP_038953141.1 | aminopeptidase Q isoform X8 |
| XM_039097211.1 | XP_038953139.1 | aminopeptidase Q isoform X6 |
| XM_039097212.1 | XP_038953140.1 | aminopeptidase Q isoform X7 |
| XM_039097214.1 | XP_038953142.1 | aminopeptidase Q isoform X9 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
aminopeptidase Q |
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
Bioactive Molecules
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS07894 | LVRN Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service